Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Myocardial production of prostaglandins: its role in atrial natriuretic peptide release

View through CrossRef
Azizi C, Barthélemy C, Masson F, Maistre G, Eurin J, Carayon A. Myocardial production of prostaglandins: its role in atrial natriuretic peptide release. Eur J Endocrinol 1995;133:255–9. ISSN 0804–4643 In recent years, considerable evidence has been accumulated on prostaglandins (PG) in modulating atrial natriuretic peptide (ANP) release. In the current study we investigated whether eicosanoids promote isoproterenol-induced ANP secretion from superfused rabbit sliced atria. Inclusion of the cyclooxygenase inhibitor indomethacin (10 μmol to the superfusing medium abolished isoproterenol-induced ANP release. Next, PGE2, but not PGF2α or PGI2 (10 μmol), increased ANP release. Furthermore, isoproterenol-induced PGE2 formation was fully attenuated by indomethacin. Dibutyl-cAMP (0.5 mmol) had no effect on PGE2 formation, and the protein kinase A (PKA) inhibitor H89 (20 μmol) did not alter isoproterenol-induced PGE2 formation. On the other hand, indomethacin led to a significant decrease in isoprotrenol-induced cAMP production. In addition, PGE2 enhanced basal cAMP concentration in superfusates. Superfusion of sliced atria by forskolin (10 μmol) or by dibutylcAMP (0.5 mmol) produced a significant rise in ANP release. Finally, H89 was ineffective on basal ANP release but abolished the increase of ANP release in response to isoproterenol or to PGE2. We conclude that: the effect of isoproterenol on ANP release is sensitive to indomethacin and H89; PGE2, but not PGF2α or PGI2, increases ANP release; isoproterenol promotes myocardial PGE2 formation independently of adenylate cyclase and PKA activation pathways; and PGE2-induced ANP release is mediated by cAMP production and subsequent PKA activation. These results suggest that isoproterenol-induced ANP release appears to be mediated at least partly by PGE2 with underlying cAMP formation and PKA activation. C Azizi, Service de Biochimie, CHU Pitié-Salpêtrère, 91 boulevard de l'hôpital, 75634 Paris Cedex 13, France
Title: Myocardial production of prostaglandins: its role in atrial natriuretic peptide release
Description:
Azizi C, Barthélemy C, Masson F, Maistre G, Eurin J, Carayon A.
Myocardial production of prostaglandins: its role in atrial natriuretic peptide release.
Eur J Endocrinol 1995;133:255–9.
ISSN 0804–4643 In recent years, considerable evidence has been accumulated on prostaglandins (PG) in modulating atrial natriuretic peptide (ANP) release.
In the current study we investigated whether eicosanoids promote isoproterenol-induced ANP secretion from superfused rabbit sliced atria.
Inclusion of the cyclooxygenase inhibitor indomethacin (10 μmol to the superfusing medium abolished isoproterenol-induced ANP release.
Next, PGE2, but not PGF2α or PGI2 (10 μmol), increased ANP release.
Furthermore, isoproterenol-induced PGE2 formation was fully attenuated by indomethacin.
Dibutyl-cAMP (0.
5 mmol) had no effect on PGE2 formation, and the protein kinase A (PKA) inhibitor H89 (20 μmol) did not alter isoproterenol-induced PGE2 formation.
On the other hand, indomethacin led to a significant decrease in isoprotrenol-induced cAMP production.
In addition, PGE2 enhanced basal cAMP concentration in superfusates.
Superfusion of sliced atria by forskolin (10 μmol) or by dibutylcAMP (0.
5 mmol) produced a significant rise in ANP release.
Finally, H89 was ineffective on basal ANP release but abolished the increase of ANP release in response to isoproterenol or to PGE2.
We conclude that: the effect of isoproterenol on ANP release is sensitive to indomethacin and H89; PGE2, but not PGF2α or PGI2, increases ANP release; isoproterenol promotes myocardial PGE2 formation independently of adenylate cyclase and PKA activation pathways; and PGE2-induced ANP release is mediated by cAMP production and subsequent PKA activation.
These results suggest that isoproterenol-induced ANP release appears to be mediated at least partly by PGE2 with underlying cAMP formation and PKA activation.
C Azizi, Service de Biochimie, CHU Pitié-Salpêtrère, 91 boulevard de l'hôpital, 75634 Paris Cedex 13, France.

Related Results

Natriuretic Peptide Receptors in Human Artery and Vein and Rabbit Vein Graft
Natriuretic Peptide Receptors in Human Artery and Vein and Rabbit Vein Graft
Abstract Natriuretic peptides elicit their biological effects by elevation of cGMP through activation of two biologically active receptors: natriuretic peptide A recept...
Cardiac natriuretic peptides and continuously monitored atrial pressures during chronic rapid pacing in pigs
Cardiac natriuretic peptides and continuously monitored atrial pressures during chronic rapid pacing in pigs
Changes in atrial natriuretic peptide (ANP), N‐terminal proatrial natriuretic peptide and brain natriuretic peptide (BNP) were evaluated in relation to continuously monitored atria...
Atrial natriuretic factor influences renal diurnal rhythm in essential hypertension.
Atrial natriuretic factor influences renal diurnal rhythm in essential hypertension.
We investigated in six patients with essential hypertension the effect of a low dose atrial natriuretic factor infusion for 5 days on the diurnal rhythm of renal electrolyte excret...
The physiology of atrial natriuretic factor
The physiology of atrial natriuretic factor
Following the discovery of the natriuretic effect of atrial extract, our laboratory attempted to dissect the possible physiological role of atrial natriuretic factor. Initial micro...
Molecular Mechanism of Blood Pressure Regulation through the Atrial Natriuretic Peptide
Molecular Mechanism of Blood Pressure Regulation through the Atrial Natriuretic Peptide
Natriuretic peptides, including atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP), and C-type natriuretic peptide (CNP), have cardioprotective effects and regulate ...
Secretion of Brain Natriuretic Peptide in Cultured Human Coronary Vascular Smooth Muscle Cells
Secretion of Brain Natriuretic Peptide in Cultured Human Coronary Vascular Smooth Muscle Cells
Abstract Brain natriuretic peptide (BNP) is a peptide of cardiac origin which regulates plasma volume as well as vascular tone and growth. Recently, we have reported...
A Single Membrane Protein Required for Atrial Secretory Granule Formation
A Single Membrane Protein Required for Atrial Secretory Granule Formation
Abstract The discovery of atrial secretory granules and the natriuretic peptides stored in them identified the atrium as an endocrine organ. Alth...
Natriuretic peptides appeared after their receptors in vertebrates
Natriuretic peptides appeared after their receptors in vertebrates
Abstract Background In mammals, the natriuretic system contains three natriuretic peptides, NPPA, NPPB and NPPC, that bind to three transmembrane re...

Back to Top